Stem Cells, Inc. Expanding Trial in Age-Related Eye Affliction - Xconomy

Stem Cells, Inc. Expanding Trial in Age-Related Eye AfflictionXconomyTaking another tack, companies such as Newark, CA-based Stem Cells, Inc. (NASDAQ: STEM) are injecting preparations of live cells into the eyes of clinical trial participants with the dry version of the disorder. The hope is that these stem cells will read more

http://blog.zandcell.com/stem-cells-inc-expanding-trial-in-age-related-eye-affliction-xconomy/?utm_source=rss&utm_medium=rss&utm_campaign=stem-cells-inc-expanding-trial-in-age-related-eye-affliction-xconomy